We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Primary Care

Journal Scan / Research · September 17, 2020

SSRIs May Increase Risk of T2D in Young Patients

JAMA Psychiatry

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Psychiatry
Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents
JAMA Psychiatry 2020 Sep 02;[EPub Ahead of Print], JW Sun, S Hernández-Díaz, S Haneuse, FT Bourgeois, SM Vine, M Olfson, BT Bateman, KF Huybrechts

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading